Data / Form D filings / AXIKIN PHARMACEUTICALS INC
AXIKIN PHARMACEUTICALS INC: Form D filings
AXIKIN PHARMACEUTICALS INC, a pharmaceuticals company in San Diego, CA, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on September 28, 2015, reports $6.5 million sold of a $11.6 million offering to 7 investors.
Find out what AXIKIN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10835 Road To The Cure, SUITE 250, San Diego, CA, 92121
- Phone
- (858) 458-1890
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1439059
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2015 | Amendment | $11,564,103 | $6,500,000 | $5,064,103 | 7 | Mar 12, 2014 | sec.gov |
| Mar 27, 2014 | New notice | $6,564,103 | $6,000,000 | $564,103 | 2 | Mar 12, 2014 | sec.gov |
| Mar 29, 2012 | New notice | $11,040,340 | $2,000,000 | $9,040,340 | 2 | Mar 15, 2012 | sec.gov |
| Aug 12, 2010 | New notice | $7,003,418 | $1,000,000 | $6,003,418 | 4 | Jul 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fred A. Middleton | Director | |
| Kevin B. Bacon | Executive Officer, Director | |
| Peter C.M. McWilliams | Executive Officer, Director | |
| Masaji C.M. Matsuoka | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 28, 2015 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AXIKIN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.